Incircular
Wednesday, June 05, 2024
Start-Up Stadium Session
Tools/Drug Development Support Tech
5B
Company Description: Incircular's mission is to advance Biotech and Pharma applications by effective stabilization of proteins using INCYPRO, a cutting-edge chemical protein engineering technology that uses a powerful combination of computational and structural design, as well as selective chemical modification. The resulting INCYPRO-stabilized proteins are generated efficiently, have increased chemo- and thermo-stability, and show reduced aggregation, overall leading to improved activities. Incircular is leveraging its patented INCYPRO technology to generate a portfolio of stabilized proteins in collaboration with Pharma and Biotech partners. Having started as a spin-off company from the VU University Amsterdam, we have so far raised 3 million USD and are currently looking for a series A funding round by 2025.
Company Website:
http://www.incircular.com
Company HQ City
Amsterdam
Company HQ State
North Holland
Company HQ Country
Netherlands
CEO/Top Company Official
Saskia Neubacher
Primary Speaker